Importantly, these in vivo results were consistent with our previous in vitro data (Supplementary Fig. S4), in which treatment with CES1 and sTRAIL mRNAs, particularly in combination with CPT-11, significantly reduced the viability of H460-Luc lung cancer cells. Here, CES1 is linked to lung cancer.